Ligand validation:4PR7

C8E: (HYDROXYETHYLOXY)TRI(ETHYLOXY)OCTANE

C8E is a Ligand Of Interest in 4PR7 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4PR7_C8E_A_306	14%	80%	0.232	0.783	0.48	0.36	-	-	0	0	100%	1
4PR7_C8E_A_305	10%	81%	0.23	0.733	0.52	0.31	-	-	0	0	100%	1
4FQE_C8E_A_306	32%	78%	0.194	0.868	0.42	0.47	-	-	3	0	100%	1
2VQI_C8E_B_1638	100%	84%	0.037	0.989	0.38	0.39	-	-	0	0	100%	1
8XWO_C8E_A_402	94%	77%	0.046	0.989	0.45	0.46	-	-	2	0	76%	1
2GR7_C8E_D_1342	83%	75%	0.098	0.955	0.42	0.56	-	-	2	0	100%	1
5FOK_C8E_A_1725	80%	74%	0.099	0.949	0.47	0.53	-	-	4	0	100%	1
3QRC_C8E_B_1	76%	86%	0.113	0.95	0.37	0.36	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.